Transine Therapeutics grabs seed
Transine Therapeutics, a developer of therapeutic RNAs, has raised 4.6 million pounds in seed funding.
Transine Therapeutics, a developer of therapeutic RNAs, has raised 4.6 million pounds in seed funding.
Copyright PEI Media
Not for publication, email or dissemination